With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
In a first report of its kind, phase 1 and 2 testing of an inactivated COVID-19 vaccine in China demonstrates effective antibody induction, particularly when administered over three injections spaced 3-4 weeks apart, with no serious adverse events. | Xia, JAMA 2020
Comments
Post a Comment